COPD trials in India

In India 6 Also abroad 559

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Where
Ahmedabad, Allahabād, Bangalore, Bhopal, Chhatrapati Sambhajinagar, Lucknow, Nagpur, New Delhi, Noida, Pune, Udaipur
Age
40 years to 75 years
People
606 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00
Phase 2Taking people
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Where
Belagavi, Coimbatore, Dehradun, Delhi, Dwārka, Hyderabad, Kochi, Mumbai, Nagpur, Vijayawada
Age
40 years and over
People
987 worldwide
Run by
AstraZeneca
See details and how to joinNCT07082738
Phase 2/3Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Belagavi, Coimbatore, Dehradun, Hyderabad, Jaipur, Kolkata, New Delhi, Thane
Age
35 years to 80 years
People
1,156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Ahmedabad, Aligarh, Belagavi, Calicut, Chandigarh, Dehradun, Delhi, Dwārka, Hyderabad, Jaipur, Kolkata, Mangalore, Mumbai, Nagpur, New Delhi, Pune, Telangana, Vijayawada
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
Phase 4Taking people
Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease
Where
Bangalore, Dalgate, Drugjan, Hyderabad, Lucknow, Nagpur, New Delhi
Age
18 years and over
People
166
Run by
AstraZeneca
See details and how to joinNCT06531798
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Where
Ahmedabad, Aligarh, Belagavi, Coimbatore, Dehradun, Delhi, Dwārka, Faridabad, Gūrgaon, Kochi, Kolkata, Kozhikode, Lucknow, Madurai, Mysuru, Nagpur, Pune, Telangana, Vadodara
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00